Thus, finding the putative m6A5044 structural switch to modulate miRNA-binding site accessibility in MALAT1 represents an intriguing mechanism to search in other modified RNAs as well as a novel biomarker and anti-cancer drug target. The gene discussed is MALAT1; the disease is cancer.